TGF-β1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60c-src/EGFRY845 and Rho/ROCK signaling

Kutz, 2001, TGF-β1-induced PAI-1 gene expression requires MEK activity and cell-to-substrate adhesion, J. Cell Sci., 114, 3905, 10.1242/jcs.114.21.3905 Yue, 2001, Transforming growth factor-beta signal transduction in epithelial cells, Pharmacol. Ther., 91, 1, 10.1016/S0163-7258(01)00143-7 Bottinger, 2002, TGF-β signaling in renal disease, J. Am. Soc. Nephrol., 13, 2600, 10.1097/01.ASN.0000033611.79556.AE Bhowmick, 2003, TGF-β-induced RhoA and p160ROCK activation is involved in the inhibition of Cdc25A with resultant cell-cycle arrest, Proc. Natl. Acad. Sci. U. S. A., 100, 15548, 10.1073/pnas.2536483100 Derynck, 2003, Smad-dependent and Smad-independent pathways in TGF-β family signalling, Nature, 425, 577, 10.1038/nature02006 Ten Dijke, 2004, New insights into TGF-β-Smad signalling, Trends Biochem. Sci., 29, 265, 10.1016/j.tibs.2004.03.008 Moustakas, 2005, Non-Smad TGF-β signals, J. Cell Sci., 118, 3573, 10.1242/jcs.02554 Allen, 2004, Plasminogen activator inhibitor type-1 expression and the pathophysiology of TGF-β1-induced epithelial-to-mesenchymal transition, Recent Res. Devel. Physiol., 2, 355 Wilkins-Port, 2007, Regulation of extracellular matrix remodeling following transforming growth factor-β1/epidermal growth factor-stimulated epithelial–mesenchymal transition in human premalignant keratinocytes, Cells Tissues Organs, 185, 116, 10.1159/000101312 Petzelbauer, 1996, Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-β1, Am. J. Pathol., 149, 923 DeYoung, 2001, Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries, Circulation, 104, 1972, 10.1161/hc4101.097110 Kaikita, 2001, Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition, Circulation, 104, 839, 10.1161/hc3301.092803 Vaughan, 2002, PAI-1 and cellular migration: dabbling in paradox, Arterioscler. Thromb. Vasc. Biol., 22, 1522, 10.1161/01.ATV.0000037901.89736.0A Vaughan, 2006, PAI-1 and TGF-β: unmasking the real driver of TGF-β-induced vascular pathology, Arterioscler. Thromb. Vasc. Biol., 26, 679, 10.1161/01.ATV.0000209949.86606.c2 Sobel, 2003, Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis, Arterioscler. Thromb. Vasc. Biol., 23, 1979, 10.1161/01.ATV.0000091250.53231.4D Eddy, 2006, Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action, J. Am. Soc. Nephrol., 17, 2999, 10.1681/ASN.2006050503 Singh, 2006, The role of transforming growth factor-β in atherosclerosis, Cytokine Growth Factor Rev., 17, 487, 10.1016/j.cytogfr.2006.09.002 Otsuka, 2006, Transforming growth factor β1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways, Arterioscler. Thromb. Vasc. Biol., 26, 737, 10.1161/01.ATV.0000201087.23877.e1 Otsuka, 2007, Mechanisms of TGF-b1-induced intimal growth. Plasminogen-independent activities of plasminogen activator inhibitor-1 and heterogeneous origin of intimal cells, Cir Res, 100, 1300, 10.1161/01.RES.0000266970.34017.8d Wang, 2006, Multiple biomarkers for the prediction of first major cardiovascular events and death, N. Engl. J. Med., 355, 2631, 10.1056/NEJMoa055373 Weisberg, 2005, Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling, Arterioscler. Thromb. Vasc. Biol., 25, 365, 10.1161/01.ATV.0000152356.85791.52 Shimokawa, 2005, Rho-kinase is an important therapeutic target in cardiovascular medicine, Arterioscler. Thromb. Vasc. Biol., 25, 1767, 10.1161/01.ATV.0000176193.83629.c8 Loirand, 2006, Rho kinases in cardiovascular physiology and pathophysiology, Circ. Res., 98, 322, 10.1161/01.RES.0000201960.04223.3c Sawada, 2000, Inhibition of rho-associated kinase results in suppression of neointimal formation of balloon-injured arteries, Circulation, 101, 2030, 10.1161/01.CIR.101.17.2030 Rikitake, 2005, Decreased perivascular fibrosis but not cardiac hypertrophy in ROCK1+/− haploinsufficient mice, Circulation, 112, 2959, 10.1161/CIRCULATIONAHA.105.584623 Takeda, 2001, Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression, Arterioscler. Thromb. Vasc. Biol., 21, 868, 10.1161/01.ATV.21.5.868 Nakakuki, 2005, Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells, Arterioscler. Thromb. Vasc. Biol., 25, 2088, 10.1161/01.ATV.0000183607.50230.9f Rikitake, 2005, Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells, Circulation, 111, 3261, 10.1161/CIRCULATIONAHA.105.534024 Zavadil, 2001, Genetic programs of epithelial cell plasticity directed by transforming growth factor-β, Proc. Natl. Acad. Sci. U. S. A., 98, 6686, 10.1073/pnas.111614398 Guo, 2005, MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-β in rat mesangial cells, Kidney Int., 68, 972, 10.1111/j.1523-1755.2005.00491.x Samarakoon, 2005, Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-β1-stimulated smooth muscle cells is pp60c-src/MEK-dependent, J. Cell Physiol., 204, 236, 10.1002/jcp.20279 Kutz, 2006, TGF-β1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling, Exp. Cell Res., 312, 1093, 10.1016/j.yexcr.2005.12.027 Woodward, 2006, Identification of intracellular pathways through which TGF-β1 upregulates PAI-1 expression in endothelial cells, Atherosclerosis, 186, 92, 10.1016/j.atherosclerosis.2005.07.026 Samarakoon, 2002, MEK/ERK pathway mediates cell-shape-dependent plasminogen activator inhibitor type 1 gene expression upon drug-induced disruption of the microfilament and microtubule networks, J. Cell Sci., 115, 3093, 10.1242/jcs.115.15.3093 Chen, 2006, RhoA modulates Smad signaling during transforming growth factor-β-induced smooth muscle differentiation, J. Biol. Chem., 281, 1765, 10.1074/jbc.M507771200 Kita, 2007, Transforming growth factor-β2 and connective tissue growth factor in proliferative vitreoretinal diseases: possible involvement of hyalocytes and therapeutic potential of Rho kinase inhibitor, Diabetes, 56, 231, 10.2337/db06-0581 Loirand, 2006, Regulation of Rho proteins by phosphorylation in the cardiovascular system, Trends in Cardiovascular Med., 16, 199, 10.1016/j.tcm.2006.03.010 Dennler, 1998, Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene, EMBO J., 17, 3091, 10.1093/emboj/17.11.3091 Hua, 1998, Synergistic cooperation of TFE3 and smad proteins in TGF-β-induced transcription of the plasminogen activator inhibitor-1 gene, Genes Dev., 12, 3084, 10.1101/gad.12.19.3084 Levy, 2005, Smad4 dependency defines two classes of transforming growth factor β (TGF-β) target genes and distinguishes TGF-β-induced epithelial–mesenchymal transition from its antiproliferative and migratory responses, Mol. Cell. Biol., 25, 8108, 10.1128/MCB.25.18.8108-8125.2005 Biscardi, 1999, c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function, J. Biol. Chem., 274, 8335, 10.1074/jbc.274.12.8335 Owens, 2004, Molecular regulation of vascular smooth muscle cell differentiation in development and disease, Physiol. Rev., 84, 767, 10.1152/physrev.00041.2003 Itoh, 2007, Negative regulation of TGF-β receptor/Smad signal transduction, Curr. Opin. Cell Biol., 19, 10.1016/j.ceb.2007.02.015 Allen, 2005, Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes, J. Cell. Physiol., 203, 156, 10.1002/jcp.20211 Higgins, 2006, TGF-β1-stimulated p21ras-ERK signaling regulates expression of the angiogenic SERPIN PAI-1, Recent Res. Develop. Biochem., 7, 31 Qi, 2006, PAI-1 transcriptional regulation during the G0→G1 transition in human epidermal keratinocytes, J. Cell. Biochem., 99, 495, 10.1002/jcb.20885 Oda, 2001, PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction, Kidney Int., 60, 587, 10.1046/j.1523-1755.2001.030002587.x Eitzman, 1996, Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene, J. Clin. Invest., 97, 232, 10.1172/JCI118396 Zhu, 2001, Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice, Circulation, 103, 3105, 10.1161/01.CIR.103.25.3105 Alessi, 2006, PAI-1 and the metabolic syndrome: links, causes, and consequences, Arterioscler. Thromb. Vasc. Biol., 26, 2200, 10.1161/01.ATV.0000242905.41404.68 Eren, 2002, Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1, Circulation, 106, 491, 10.1161/01.CIR.0000023186.60090.FB Jones, 1979, Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells, Proc. Natl. Acad. Sci. U. S. A., 76, 353, 10.1073/pnas.76.1.353